Aurora Spine Corporation (TSXV: ASG)

Market Cap	33.29M
Revenue (ttm)	22.84M
Net Income (ttm)	-858.54K
Shares Out	77.42M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.450
Previous Close	0.430
Day's Range	0.450 - 0.450
52-Week Range	0.220 - 0.470
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 15, 2024

About Aurora Spine

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed tita...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: ASG

Financial Performance

In 2023, Aurora Spine's revenue was $14.52 million, a decrease of -2.40% compared to the previous year's $14.88 million. Losses were -$1.68 million, 11.9% more than in 2022.

Financial numbers in USD